Retour
Fourchette du Jour
104,90 €
104,98 €
Fourchette 52 Semaines
38,81 €
104,98 €
Volume
21 562 141
Moyenne 50J / 200J
103,02 €
/
74,29 €
Clôture Précédente
104,91 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -96,3 | 0,3 |
| P/B | 8,3 | 2,9 |
| ROE % | -8,7 | 3,7 |
| Net Margin % | -6,4 | 3,8 |
| Rev Growth 5Y % | 16,4 | 10,0 |
| D/E | 1,1 | 0,2 |
Objectif de Cours des Analystes
Hold
103,18 €
-1.6%
Low: 85,00 €
High: 105,00 €
P/E Prévisionnel
582,8
BPA Prévisionnel
0,18 €
Croissance BPA (est.)
+0,0%
CA Est.
3,7 B
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
3,13 €
2,82 € – 3,28 €
|
5,1 B | 1 |
| FY2029 |
2,09 €
1,88 € – 2,18 €
|
4,9 B | 1 |
| FY2028 |
1,74 €
0,94 € – 2,41 €
|
4,6 B | 5 |
Points Clés
Revenue grew 16,43% annually over 5 years — strong growth
Generating 356,78M in free cash flow
Capital efficient — spends only 4,15% of revenue on capex
Croissance
Revenue Growth (5Y)
16,43%
Revenue (1Y)17,69%
Earnings (1Y)N/A
FCF Growth (3Y)234,28%
Qualité
Return on Equity
-8,66%
ROIC-1,51%
Net Margin-6,40%
Op. Margin-3,05%
Sécurité
Debt / Equity
1,05
Current Ratio2,43
Interest Coverage-3,01
Valorisation
P/E Ratio
-96,30
P/B Ratio8,34
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 17,69% | Revenue Growth (3Y) | 13,97% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 16,43% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 3,25B | Net Income (TTM) | -207,95M |
| ROE | -8,66% | ROA | -3,55% |
| Gross Margin | 69,69% | Operating Margin | -3,05% |
| Net Margin | -6,40% | Free Cash Flow (TTM) | 356,78M |
| ROIC | -1,51% | FCF Growth (3Y) | 234,28% |
| Safety | |||
| Debt / Equity | 1,05 | Current Ratio | 2,43 |
| Interest Coverage | -3,01 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -96,30 | P/B Ratio | 8,34 |
| P/S Ratio | 6,17 | PEG Ratio | 1,15 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 20,03B | Enterprise Value | 21,59B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 3,25B | 2,76B | 2,50B | 2,08B | 1,77B |
| Net Income | -207,95M | -1,03B | -204,15M | -623,51M | -595,63M |
| EPS (Diluted) | -1,10 | -5,59 | -1,13 | -3,54 | -3,48 |
| Gross Profit | 2,26B | 1,92B | 1,76B | 1,42B | 1,31B |
| Operating Income | -99,08M | -1,05B | -215,01M | -593,51M | -855,68M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 5,86B | 5,93B | 6,47B | 6,23B | 6,68B |
| Total Liabilities | 3,46B | 3,53B | 3,33B | 3,18B | 3,30B |
| Shareholders' Equity | 2,40B | 2,40B | 3,15B | 3,04B | 3,39B |
| Total Debt | 2,52B | 2,75B | 2,55B | 2,45B | 2,38B |
| Cash & Equivalents | 956,00M | 600,89M | 605,38M | 242,49M | 315,47M |
| Current Assets | 1,56B | 1,57B | 1,19B | 982,26M | 1,43B |
| Current Liabilities | 641,15M | 732,19M | 514,70M | 412,75M | 517,07M |